Biomarker development, commercialization, and regulation: individualization of medicine lost in translation.
Wilson
C
C
Schulz
S
S
Waldman
S A
SA
D015415:Biomarkers; D017277:Drug Approval; D006801:Humans; D040541:Marketing / Q000379:methods*; D009316:National Institutes of Health (U.S.); D013678:Technology, Pharmaceutical / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration
D015415:Biomarkers